Uteroglobin, a possible ligand of the lipoxin receptor inhibits serum amyloid A-driven inflammation

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Antico, Giovanni ^a   Aloman, Monica ^b   Lakota, Katja ^c   Miele, Lucio ^d   Fiore, Stefano ^e   Sodin Semrl, Snezna ^c,f  

^a ASTELLAS PHARMA GLOBAL DEVELOPMENT   (United States)

^b ADVOCATE CHRIST MEDICAL CENTER   (United States)

^c UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^d UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^e SANOFI   (France)

^f UNIVERSITY OF PRIMORSKA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; GLOBULAR PROTEIN; INTERLEUKIN 8; LIPOXIN A; LIPOXIN RECEPTOR; PHOSPHOLIPASE A2; SERUM AMYLOID A; UTEROGLOBIN; LIGAND; SCGB1A1 PROTEIN, HUMAN;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BONE EROSION; CELL LINE; CELL MIGRATION; CHEMOTAXIS; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME IMMUNOASSAY; FIBROBLAST; GENETIC POLYMORPHISM; GLOMERULONEPHRITIS; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; INFLAMMATION; MOLECULAR INTERACTION; NEGATIVE FEEDBACK; NONHUMAN; RHEUMATOID ARTHRITIS; SARCOIDOSIS; SYNOVIOCYTE; SYNOVIUM; ANIMAL; CELL MOTION; CHO CELL LINE; CRICETULUS; CYTOLOGY; ENDOMETRIUM; FEMALE; HL 60 CELL LINE; METABOLISM; PROMOTER REGION;

ANIMALS; CELL MOVEMENT; CHEMOTAXIS; CHO CELLS; CRICETULUS; ENDOMETRIUM; FEMALE; FIBROBLASTS; HL-60 CELLS; HUMANS; IMMUNOENZYME TECHNIQUES; INFLAMMATION; LIGANDS; PHOSPHOLIPASES A2; PROMOTER REGIONS, GENETIC; RECEPTORS, LIPOXIN; SERUM AMYLOID A PROTEIN; SYNOVIAL MEMBRANE; UTEROGLOBIN;

EID: 84899478469     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/876395     Document Type: Article

References (46)

1. Cunnane G., Grehan S., Geoghegan S., Mccormack C., Shields D., Whitehead A. S., Bresnihan B., Fitzgerald O., Serum amyloid A in the assessment of early inflammatory arthritis. Journal of Rheumatology 2000 27 1 58 63 2-s2.0-0033970903 (Pubitemid 30058629)
2. Gabay C., Kushner I., Acute-phase proteins and other systemic responses to inflammation. The New England Journal of Medicine 1999 340 6 448 454 2-s2.0-0033545342 10.1056/NEJM199902113400607 (Pubitemid 29084777)
3. Okamoto H., Katagiri Y., Kiire A., Momohara S., Kamatani N., Serum amyloid A activates nuclear factor- B in rheumatoid synovial fibroblasts through binding to receptor of advanced glycation end-products. Journal of Rheumatology 2008 35 5 752 756 2-s2.0-44349189334 (Pubitemid 351747112)
4. Sodin-Semrl S., Spagnolo A., Mikus R., Barbaro B., Varga J., Fiore S., Opposing regulation of interleukin-8 and NF-kB responses by lipoxin A4 and serum amyloid a via the common lipoxin a receptor. International Journal of Immunopathology and Pharmacology 2004 17 2 145 156 2-s2.0-9644303534
5. Sodin-Semrl S., Taddeo B., Tseng D., Varga J., Fiore S., Lipoxin A4 inhibits IL-1 β -induced IL-6, IL-8, and matrix metalloproteinase-3 production in human synovial fibroblasts and enhances synthesis of tissue inhibitors of metalloproteinases. Journal of Immunology 2000 164 5 2660 2666 2-s2.0-0034144689 (Pubitemid 30115498)
6. Su S. B., Gong W., Gao J.-L., Shen W., Murphy P. M., Oppenheim J. J., Wang J. M., A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells. Journal of Experimental Medicine 1999 189 2 395 402 2-s2.0-0000485181 10.1084/jem.189.2.395 (Pubitemid 29063260)
7. Badolato R., Wang J. M., Murphy W. J., Lloyd A. R., Michiel D. F., Bausserman L. L., Kelvin D. J., Oppenheim J. J., Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes. Journal of Experimental Medicine 1994 180 1 203 209 2-s2.0-23444460848 10.1084/jem.180.1.203 (Pubitemid 24181069)
8. Resnati M., Pallavicini I., Wang J. M., Oppenheim J., Serhan C. N., Romano M., Blasi F., The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R. Proceedings of the National Academy of Sciences of the United States of America 2002 99 3 1359 1364 2-s2.0-0037022391 10.1073/pnas.022652999 (Pubitemid 34136498)
9. Le Y., Murphy P. M., Wang J. M., Formyl-peptide receptors revisited. Trends in Immunology 2002 23 11 541 548 2-s2.0-0036839229 10.1016/S1471-4906(02) 02316-5 (Pubitemid 35223553)
10. Fiore S., Maddox J. F., Perez H. D., Serhan C. N., Identification of a human cDNA encoding a functional high affinity lipoxin A4 receptor. Journal of Experimental Medicine 1994 180 1 253 260 2-s2.0-0028359379 10.1084/jem.180.1.253 (Pubitemid 24181074)
11. Takano T., Fiore S., Maddox J. F., Brady H. R., Petasis N. A., Serhan C. N., Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors. Journal of Experimental Medicine 1997 185 9 1693 1704 2-s2.0-0030924291 10.1084/jem.185.9.1693 (Pubitemid 27203265)
12. Fiore S., Serhan C. N., Lipoxin A4 receptor activation is distinct from that of the formyl peptide receptor in myeloid cells: inhibition of CD11/18 expression by lipoxin A4-lipoxin A4 receptor interaction. Biochemistry 1995 34 51 16678 16686 2-s2.0-0029417201
13. Perretti M., Chiang N., La M., Fierro I. M., Marullo S., Getting S. J., Solito E., Serhan C. N., Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor. Nature Medicine 2002 8 11 1296 1302 2-s2.0-0036852720 10.1038/nm786 (Pubitemid 35373563)
14. Miele L., Cordella-Miele E., Facchiano A., Mukherjee A. B., Inhibition of phospholipase A2 by uteroglobin and antiflammin peptides. Advances in Experimental Medicine and Biology 1990 279 137 160 2-s2.0-0025571506
15. Miele L., Cordella-Miele E., Mukherjee A. B., Uteroglobin: structure, molecular biology, and new perspectives on its function as a phospholipase A2 inhibitor. Endocrine Reviews 1987 8 4 474 490 2-s2.0-0023444081
16. Mukherjee A. B., Cordella-Miele E., Kikukawa T., Miele L., Modulation of cellular response to antigens by uteroglobin and transglutaminase. Advances in Experimental Medicine and Biology 1988 231 135 152 2-s2.0-0023718062
17. Miele L., Cordella-Miele E., Facchiano A., Mukherjee A. B., Novel anti-inflammatory peptides from the region of highest similarity between uteroglobin and lipocortin I. Nature 1988 335 6192 726 730 2-s2.0-0023683668
18. Miele L., Bioactive peptides derived from uteroglobin. Annals of the New York Academy of Sciences 2000 923 128 140 2-s2.0-0034567899 (Pubitemid 32050210)
19. Marki F., Pfeilschifter J., Rink H., Wiesenberg I., 'Antiflammins': two nonapeptide fragments of uteroglobin and lipocortin I have no phospholipase A2-inhibitory and anti-inflammatory activity. FEBS Letters 1990 264 2 171 175 2-s2.0-0025351630 10.1016/0014-5793(90)80241-A (Pubitemid 20169209)
20. Moreno J. J., Antiflammins: endogenous nonpeptides with regulatory effect on inflammation. General Pharmacology 1997 28 1 23 26 2-s2.0-0030610417 10.1016/S0306-3623(96)00151-6 (Pubitemid 27016054)
21. Moreno J. J., Antiflammin peptides in the regulation of inflammatory response. Annals of the New York Academy of Sciences 2000 923 147 153 2-s2.0-0034501374 (Pubitemid 32050212)
22. Vasanthakumar G., Manjunath R., Mukherjee A. B., Warabi H., Schiffmann E., Inhibition of phagocyte chemotaxis by uteroglobin, an inhibitor of blastocyst rejection. Biochemical Pharmacology 1988 37 3 389 394 2-s2.0-0023855294 10.1016/0006-2952(88)90204-3 (Pubitemid 18027346)
23. Dierynck I., Bernard A., Roels H., De Ley M., The human Clara cell protein: biochemical and biological characterisation of a natural immunosuppressor. Multiple Sclerosis 1996 1 6 385 387 2-s2.0-0030178485 (Pubitemid 126701303)
24. Camussi G., Tetta C., Bussolino F., Baglioni C., Antiinflammatory peptides (antiflammins) inhibit synthesis of platelet-activating factor, neutrophil aggregation and chemotaxis, and intradermal inflammatory reactions. Journal of Experimental Medicine 1990 171 3 913 927 2-s2.0-0025303768 (Pubitemid 20088991)
25. Schiffmann E., Geetha V., Pencev D., Warabi H., Mato J., Hirata F., Brownstein M., Manjunath R., Mukherjee A., Liotta L., Terranova V. P., Adherence and regulation of leukotaxis. Agents and Actions 1983 12 106 120 2-s2.0-0020667179
26. Facchiano A., Cordella-Miele E., Miele L., Mukherjee A. B., Inhibition of pancreatic phospholipase A2 activity by uteroglobin and antiflammin peptides: possible mechanism of action. Life Sciences 1991 48 5 453 464 2-s2.0-0026098750 10.1016/0024-3205(91)90501-2
27. Moreno J. J., Effects of antiflammins on transglutaminase and phospholipase A2 activation by transglutaminase. International Immunopharmacology 2006 6 2 300 303 2-s2.0-30144440390 10.1016/j.intimp.2005.08. 001 (Pubitemid 43052828)
28. Hope W. C., Patel B. J., Rolin D. R., Antiflammin-2 (HDMNKVLDL) does not inhibit phospholipase A2 activities. Agents and Actions 1991 34 1-2 77 80 2-s2.0-0025784157
29. Kamal A. M., Hayhoe R. P. G., Paramasivam A., Cooper D., Flower R. J., Solito E., Perretti M., Antiflammin-2 activates the human formyl-peptide receptor like 1. TheScientificWorldJournal 2006 6 1375 1384 2-s2.0-33750826391 10.1100/tsw.2006.247 (Pubitemid 44715631)
30. Mango G. W., Johnston C. J., Reynolds S. D., Finkelstein J. N., Plopper C. G., Stripp B. R., Clara cell secretory protein deficiency increases oxidant stress response in conducting airways. The American Journal of Physiology: Lung Cellular and Molecular Physiology 1998 275 2 L348 L356 2-s2.0-0031845602
31. Harrod K. S., Mounday A. D., Stripp B. R., Whitsett J. A., Clara cell secretory protein decreases lung inflammation after acute virus infection. The American Journal of Physiology: Lung Cellular and Molecular Physiology 1998 275 5 L924 L930 2-s2.0-0031765343
32. Kikukawa T., Cowan B. D., Tejada R. I., Mukherjee A. B., Partial characterization of a uteroglobin-like protein in the human uterus and its temporal relationship to prostaglandin levels in this organ. Journal of Clinical Endocrinology and Metabolism 1988 67 2 315 321 2-s2.0-0023694330
33. Mukherjee A. B., Kundu G. C., Mandal A. K., Pattabiraman N., Yuan C.-J., Zhang Z., Uteroglobin: physiological role in normal glomerular function uncovered by targeted disruption of the uteroglobin gene in mice. The American Journal of Kidney Diseases 1998 32 6 1106 1120 2-s2.0-0031769505 (Pubitemid 28551181)
34. Fiore S., Romano M., Reardon E. M., Serhan C. N., Induction of functional lipoxin A4 receptors in HL-60 cells. Blood 1993 81 12 3395 3403 2-s2.0-0027233842 (Pubitemid 23172926)
35. Nigam S., Fiore S., Luscinskas F. W., Serhan C. N., Lipoxin A4 and lipoxin B4 stimulate the release but not the oxygenation of arachidonic acid in human neutrophils: dissociation between lipid remodeling and adhesion. Journal of Cellular Physiology 1990 143 3 512 523 2-s2.0-0025193845 10.1002/jcp. 1041430316 (Pubitemid 20201668)
36. Antico G., Lingen M. W., Sassano A., Melby J., Welch R. W., Fiore S., Pilon A. L., Miele L., Recombinant human uteroglobin/CC10 inhibits the adhesion and migration of primary human endothelial cells via specific and saturable binding to fibronectin. Journal of Cellular Physiology 2006 207 2 553 561 2-s2.0-33645686640 10.1002/jcp.20604
37. Mukherjee A. B., Zhang Z., Chilton B. S., Uteroglobin: a steroid-inducible immunomodulatory protein that founded the Secretoglobin superfamily. Endocrine Reviews 2007 28 7 707 725 2-s2.0-37349074529 10.1210/er.2007-0018 (Pubitemid 350294292)
38. 2+ and leukotriene B4. The American Journal of Physiology: Cell Physiology 1995 268 1 C138 C146 2-s2.0-0028870492
39. Serhan C. N., Broekman M. J., Korchak H. M., Endogenous phospholipid metabolism in stimulated neutrophils: differential activation by FMLP and PMA. Biochemical and Biophysical Research Communications 1982 107 3 951 958 2-s2.0-0020465147 (Pubitemid 13207678)
40. Ray R., Zhang Z., Lee Y.-C., Gao J.-L., Mukherjee A. B., Uteroglobin suppresses allergen-induced TH2 differentiation by down-regulating the expression of serum amyloid A and SOCS-3 genes. FEBS Letters 2006 580 25 6022 6026 2-s2.0-33750993188 10.1016/j.febslet.2006.09.059 (Pubitemid 44739943)
41. Goronzy J. J., Matteson E. L., Fulbright J. W., Warrington K. J., Chang-Miller A., Hunder G. G., Mason T. G., Nelson A. M., Valente R. M., Crowson C. S., Erlich H. A., Reynolds R. L., Swee R. G., O'Fallon W. M., Weyand C. M., Prognostic markers of radiographic progression in early rheumatoid arthritis. Arthritis and Rheumatism 2004 50 1 43 54 2-s2.0-9144259305 10.1002/art.11445 (Pubitemid 38084286)
42. Pilon A. L., Rationale for the development of recombinant human CC10, as a therapeutic for inflammatory and fibrotic disease. Annals of the New York Academy of Sciences 2000 923 280 299 2-s2.0-0034502441 (Pubitemid 32050221)
43. Lee Y.-C., Zhang Z., Mukherjee A. B., Mice lacking uteroglobin are highly susceptible to developing pulmonary fibrosis. FEBS Letters 2006 580 18 4515 4520 2-s2.0-33746509707 10.1016/j.febslet.2006.07.031 (Pubitemid 44137353)
44. Mukherjee A. B., Zheng F., Zhang Z., Uteroglobin in the treatment of IgA mediated disease. United States Patent 2011 US 8, 084, 415 B2
45. Peri A., Cordella-Miele E., Miele L., Mukherjee A. B., Tissue-specific expression of the gene coding for human Clara cell 10-kD protein, a phospholipase A2-inhibitory protein. Journal of Clinical Investigation 1993 92 5 2099 2109 2-s2.0-0027360818 (Pubitemid 23333512)
46. Peri A., Cowan B. D., Bhartiya D., Miele L., Nieman L. K., Nwaeze I. O., Mukherjee A. B., Expression of Clara cell 10-kD gene in the human endometrium and its relationship to ovarian menstrual cycle. DNA and Cell Biology 1994 13 5 495 503 2-s2.0-0028083280 (Pubitemid 24291403)